Forecasting The Future: 4 Analyst Projections For Tango Therapeutics
Portfolio Pulse from Benzinga Insights
Analysts have mixed ratings for Tango Therapeutics (NASDAQ:TNGX) with recent adjustments showing a decline in price targets. The average 12-month price target is now $14.5, down 16.33% from the prior average. Key analysts from Barclays, Wedbush, and HC Wainwright & Co. have lowered their targets, reflecting cautious sentiment.
May 24, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Analysts have mixed ratings for Tango Therapeutics with recent adjustments showing a decline in price targets. The average 12-month price target is now $14.5, down 16.33% from the prior average. Key analysts from Barclays, Wedbush, and HC Wainwright & Co. have lowered their targets, reflecting cautious sentiment.
The decline in average price targets and the lowering of targets by key analysts indicate a cautious sentiment towards Tango Therapeutics. This is likely to have a negative short-term impact on the stock price as investors react to the revised expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100